GO:0010829 | negative regulation of glucose transmembrane transport | 20.0% (1/5) | 11.35 | 0.000384 | 0.012346 |
GO:0045649 | regulation of macrophage differentiation | 20.0% (1/5) | 11.35 | 0.000384 | 0.012346 |
GO:0045651 | positive regulation of macrophage differentiation | 20.0% (1/5) | 11.35 | 0.000384 | 0.012346 |
GO:0046325 | negative regulation of glucose import | 20.0% (1/5) | 11.35 | 0.000384 | 0.012346 |
GO:0048265 | response to pain | 20.0% (1/5) | 11.35 | 0.000384 | 0.012346 |
GO:0004865 | protein serine/threonine phosphatase inhibitor activity | 20.0% (1/5) | 11.35 | 0.000384 | 0.012346 |
GO:0008995 | ribonuclease E activity | 20.0% (1/5) | 11.35 | 0.000384 | 0.012346 |
GO:0002062 | chondrocyte differentiation | 20.0% (1/5) | 10.35 | 0.000767 | 0.013116 |
GO:0034103 | regulation of tissue remodeling | 20.0% (1/5) | 10.35 | 0.000767 | 0.013116 |
GO:0034110 | regulation of homotypic cell-cell adhesion | 20.0% (1/5) | 10.35 | 0.000767 | 0.013116 |
GO:0045822 | negative regulation of heart contraction | 20.0% (1/5) | 10.35 | 0.000767 | 0.013116 |
GO:0046850 | regulation of bone remodeling | 20.0% (1/5) | 10.35 | 0.000767 | 0.013116 |
GO:0099171 | presynaptic modulation of chemical synaptic transmission | 20.0% (1/5) | 10.35 | 0.000767 | 0.013116 |
GO:1903523 | negative regulation of blood circulation | 20.0% (1/5) | 10.35 | 0.000767 | 0.013116 |
GO:0032423 | regulation of mismatch repair | 20.0% (1/5) | 10.61 | 0.000639 | 0.013991 |
GO:0032425 | positive regulation of mismatch repair | 20.0% (1/5) | 10.61 | 0.000639 | 0.013991 |
GO:0050927 | positive regulation of positive chemotaxis | 20.0% (1/5) | 10.61 | 0.000639 | 0.013991 |
GO:0060291 | long-term synaptic potentiation | 20.0% (1/5) | 10.61 | 0.000639 | 0.013991 |
GO:1903859 | regulation of dendrite extension | 20.0% (1/5) | 10.61 | 0.000639 | 0.013991 |
GO:1903861 | positive regulation of dendrite extension | 20.0% (1/5) | 10.61 | 0.000639 | 0.013991 |
GO:0010543 | regulation of platelet activation | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:0035408 | obsolete histone H3-T6 phosphorylation | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:0035866 | alphav-beta3 integrin-PKCalpha complex | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:0045780 | positive regulation of bone resorption | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:0050930 | induction of positive chemotaxis | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:0051412 | response to corticosterone | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:0090330 | regulation of platelet aggregation | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:1990911 | response to psychosocial stress | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:2000705 | regulation of dense core granule biogenesis | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:2000707 | positive regulation of dense core granule biogenesis | 20.0% (1/5) | 11.93 | 0.000256 | 0.013993 |
GO:0044305 | calyx of Held | 20.0% (1/5) | 10.93 | 0.000512 | 0.014728 |
GO:0045124 | regulation of bone resorption | 20.0% (1/5) | 10.93 | 0.000512 | 0.014728 |
GO:0032095 | regulation of response to food | 20.0% (1/5) | 10.13 | 0.000895 | 0.014838 |
GO:0017080 | sodium channel regulator activity | 20.0% (1/5) | 9.76 | 0.001151 | 0.018514 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 20.0% (1/5) | 9.61 | 0.001279 | 0.019427 |
GO:0051385 | response to mineralocorticoid | 20.0% (1/5) | 9.61 | 0.001279 | 0.019427 |
GO:0014704 | intercalated disc | 20.0% (1/5) | 9.47 | 0.001406 | 0.020244 |
GO:0060384 | innervation | 20.0% (1/5) | 9.47 | 0.001406 | 0.020244 |
GO:0050926 | regulation of positive chemotaxis | 20.0% (1/5) | 9.35 | 0.001534 | 0.021517 |
GO:0002026 | regulation of the force of heart contraction | 20.0% (1/5) | 9.13 | 0.00179 | 0.021754 |
GO:0008200 | ion channel inhibitor activity | 20.0% (1/5) | 9.13 | 0.00179 | 0.021754 |
GO:0016248 | channel inhibitor activity | 20.0% (1/5) | 9.13 | 0.00179 | 0.021754 |
GO:0044291 | cell-cell contact zone | 20.0% (1/5) | 9.13 | 0.00179 | 0.021754 |
GO:0004697 | protein kinase C activity | 20.0% (1/5) | 9.23 | 0.001662 | 0.022172 |
GO:0004698 | calcium-dependent protein kinase C activity | 20.0% (1/5) | 9.23 | 0.001662 | 0.022172 |
GO:0021955 | central nervous system neuron axonogenesis | 20.0% (1/5) | 9.03 | 0.001917 | 0.0228 |
GO:0050729 | positive regulation of inflammatory response | 20.0% (1/5) | 8.85 | 0.002173 | 0.02377 |
GO:0051965 | positive regulation of synapse assembly | 20.0% (1/5) | 8.85 | 0.002173 | 0.02377 |
GO:1901890 | positive regulation of cell junction assembly | 20.0% (1/5) | 8.85 | 0.002173 | 0.02377 |
GO:0010766 | negative regulation of sodium ion transport | 20.0% (1/5) | 8.93 | 0.002045 | 0.023801 |
GO:0015459 | potassium channel regulator activity | 20.0% (1/5) | 8.76 | 0.0023 | 0.024199 |
GO:0043679 | axon terminus | 20.0% (1/5) | 8.76 | 0.0023 | 0.024199 |
GO:0010613 | positive regulation of cardiac muscle hypertrophy | 20.0% (1/5) | 8.29 | 0.003194 | 0.025693 |
GO:0014742 | positive regulation of muscle hypertrophy | 20.0% (1/5) | 8.29 | 0.003194 | 0.025693 |
GO:0044306 | neuron projection terminus | 20.0% (1/5) | 8.29 | 0.003194 | 0.025693 |
GO:0099524 | postsynaptic cytosol | 20.0% (1/5) | 8.29 | 0.003194 | 0.025693 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 20.0% (1/5) | 8.54 | 0.002683 | 0.025752 |
GO:0005178 | integrin binding | 20.0% (1/5) | 8.54 | 0.002683 | 0.025752 |
GO:0030593 | neutrophil chemotaxis | 20.0% (1/5) | 8.54 | 0.002683 | 0.025752 |
GO:0046324 | regulation of glucose import | 20.0% (1/5) | 8.54 | 0.002683 | 0.025752 |
GO:0071621 | granulocyte chemotaxis | 20.0% (1/5) | 8.54 | 0.002683 | 0.025752 |
GO:0010827 | regulation of glucose transmembrane transport | 20.0% (1/5) | 8.41 | 0.002939 | 0.025928 |
GO:0097530 | granulocyte migration | 20.0% (1/5) | 8.41 | 0.002939 | 0.025928 |
GO:1990266 | neutrophil migration | 20.0% (1/5) | 8.41 | 0.002939 | 0.025928 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 20.0% (1/5) | 8.47 | 0.002811 | 0.026063 |
GO:1900077 | negative regulation of cellular response to insulin stimulus | 20.0% (1/5) | 8.47 | 0.002811 | 0.026063 |
GO:0033555 | multicellular organismal response to stress | 20.0% (1/5) | 8.35 | 0.003066 | 0.026208 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 20.0% (1/5) | 8.35 | 0.003066 | 0.026208 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 20.0% (1/5) | 8.18 | 0.003449 | 0.026573 |
GO:0004864 | protein phosphatase inhibitor activity | 20.0% (1/5) | 8.18 | 0.003449 | 0.026573 |
GO:0019212 | phosphatase inhibitor activity | 20.0% (1/5) | 8.18 | 0.003449 | 0.026573 |
GO:0051963 | regulation of synapse assembly | 20.0% (1/5) | 8.07 | 0.003704 | 0.027382 |
GO:0097529 | myeloid leukocyte migration | 20.0% (1/5) | 8.07 | 0.003704 | 0.027382 |
GO:0099523 | presynaptic cytosol | 20.0% (1/5) | 8.07 | 0.003704 | 0.027382 |
GO:0001750 | photoreceptor outer segment | 20.0% (1/5) | 8.03 | 0.003832 | 0.027579 |
GO:0050806 | positive regulation of synaptic transmission | 20.0% (1/5) | 8.03 | 0.003832 | 0.027579 |
GO:0007635 | chemosensory behavior | 20.0% (1/5) | 7.98 | 0.003959 | 0.027766 |
GO:0030595 | leukocyte chemotaxis | 20.0% (1/5) | 7.98 | 0.003959 | 0.027766 |
GO:0099106 | ion channel regulator activity | 20.0% (1/5) | 7.93 | 0.004087 | 0.028297 |
GO:0016247 | channel regulator activity | 20.0% (1/5) | 7.85 | 0.004342 | 0.028614 |
GO:0046928 | regulation of neurotransmitter secretion | 20.0% (1/5) | 7.85 | 0.004342 | 0.028614 |
GO:0051588 | regulation of neurotransmitter transport | 20.0% (1/5) | 7.85 | 0.004342 | 0.028614 |
GO:0009931 | calcium-dependent protein serine/threonine kinase activity | 20.0% (1/5) | 7.61 | 0.005106 | 0.028796 |
GO:0045639 | positive regulation of myeloid cell differentiation | 20.0% (1/5) | 7.61 | 0.005106 | 0.028796 |
GO:0060326 | cell chemotaxis | 20.0% (1/5) | 7.61 | 0.005106 | 0.028796 |
GO:1902107 | positive regulation of leukocyte differentiation | 20.0% (1/5) | 7.61 | 0.005106 | 0.028796 |
GO:1903305 | regulation of regulated secretory pathway | 20.0% (1/5) | 7.61 | 0.005106 | 0.028796 |
GO:1903708 | positive regulation of hemopoiesis | 20.0% (1/5) | 7.61 | 0.005106 | 0.028796 |
GO:0140678 | molecular function inhibitor activity | 20.0% (1/5) | 7.89 | 0.004214 | 0.028816 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 20.0% (1/5) | 7.57 | 0.005234 | 0.028918 |
GO:1901888 | regulation of cell junction assembly | 20.0% (1/5) | 7.57 | 0.005234 | 0.028918 |
GO:0046626 | regulation of insulin receptor signaling pathway | 20.0% (1/5) | 7.54 | 0.005361 | 0.029036 |
GO:0070555 | response to interleukin-1 | 20.0% (1/5) | 7.54 | 0.005361 | 0.029036 |
GO:0043502 | regulation of muscle adaptation | 20.0% (1/5) | 7.51 | 0.005489 | 0.029148 |
GO:0099522 | cytosolic region | 20.0% (1/5) | 7.51 | 0.005489 | 0.029148 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 20.0% (1/5) | 7.47 | 0.005616 | 0.029538 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 20.0% (1/5) | 7.72 | 0.004724 | 0.029703 |
GO:0014072 | response to isoquinoline alkaloid | 20.0% (1/5) | 7.72 | 0.004724 | 0.029703 |
GO:0014743 | regulation of muscle hypertrophy | 20.0% (1/5) | 7.72 | 0.004724 | 0.029703 |
GO:0043278 | response to morphine | 20.0% (1/5) | 7.72 | 0.004724 | 0.029703 |
GO:0010360 | negative regulation of anion channel activity | 20.0% (1/5) | 7.44 | 0.005743 | 0.02992 |
GO:0010930 | negative regulation of auxin mediated signaling pathway | 20.0% (1/5) | 7.65 | 0.004979 | 0.029929 |
GO:0050839 | cell adhesion molecule binding | 20.0% (1/5) | 7.65 | 0.004979 | 0.029929 |
GO:0050900 | leukocyte migration | 20.0% (1/5) | 7.65 | 0.004979 | 0.029929 |
GO:0048660 | regulation of smooth muscle cell proliferation | 20.0% (1/5) | 7.41 | 0.005871 | 0.030012 |
GO:0050921 | positive regulation of chemotaxis | 20.0% (1/5) | 7.41 | 0.005871 | 0.030012 |
GO:1900076 | regulation of cellular response to insulin stimulus | 20.0% (1/5) | 7.68 | 0.004852 | 0.030157 |
GO:0002028 | regulation of sodium ion transport | 20.0% (1/5) | 7.35 | 0.006125 | 0.030185 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 20.0% (1/5) | 7.35 | 0.006125 | 0.030185 |
GO:1903792 | negative regulation of anion transport | 20.0% (1/5) | 7.35 | 0.006125 | 0.030185 |
GO:1903960 | negative regulation of anion transmembrane transport | 20.0% (1/5) | 7.35 | 0.006125 | 0.030185 |
GO:0045921 | positive regulation of exocytosis | 20.0% (1/5) | 7.29 | 0.00638 | 0.031159 |
GO:0010857 | calcium-dependent protein kinase activity | 20.0% (1/5) | 7.2 | 0.006762 | 0.032731 |
GO:1904063 | negative regulation of cation transmembrane transport | 20.0% (1/5) | 7.18 | 0.006889 | 0.033054 |
GO:0098772 | molecular function regulator activity | 40.0% (2/5) | 3.86 | 0.00715 | 0.034011 |
GO:0045739 | positive regulation of DNA repair | 20.0% (1/5) | 7.1 | 0.00727 | 0.034284 |
GO:1902105 | regulation of leukocyte differentiation | 20.0% (1/5) | 7.03 | 0.007652 | 0.035774 |
GO:1901799 | negative regulation of proteasomal protein catabolic process | 20.0% (1/5) | 6.96 | 0.008033 | 0.037239 |
GO:0006937 | regulation of muscle contraction | 20.0% (1/5) | 6.93 | 0.00816 | 0.03751 |
GO:0007409 | axonogenesis | 20.0% (1/5) | 6.87 | 0.008542 | 0.038613 |
GO:0043524 | negative regulation of neuron apoptotic process | 20.0% (1/5) | 6.87 | 0.008542 | 0.038613 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 20.0% (1/5) | 6.85 | 0.008669 | 0.038866 |
GO:0050764 | regulation of phagocytosis | 20.0% (1/5) | 6.82 | 0.008796 | 0.039115 |
GO:0036289 | peptidyl-serine autophosphorylation | 20.0% (1/5) | 6.78 | 0.00905 | 0.03992 |
GO:0016787 | hydrolase activity | 60.0% (3/5) | 2.55 | 0.009166 | 0.040111 |
GO:0031397 | negative regulation of protein ubiquitination | 20.0% (1/5) | 6.68 | 0.009684 | 0.040438 |
GO:0050727 | regulation of inflammatory response | 20.0% (1/5) | 6.68 | 0.009684 | 0.040438 |
GO:0019208 | phosphatase regulator activity | 20.0% (1/5) | 6.68 | 0.009684 | 0.040438 |
GO:0035556 | intracellular signal transduction | 40.0% (2/5) | 3.65 | 0.009463 | 0.040441 |
GO:0006469 | negative regulation of protein kinase activity | 20.0% (1/5) | 6.72 | 0.009431 | 0.040618 |
GO:0019888 | protein phosphatase regulator activity | 20.0% (1/5) | 6.72 | 0.009431 | 0.040618 |
GO:0032410 | negative regulation of transporter activity | 20.0% (1/5) | 6.49 | 0.01108 | 0.041798 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 20.0% (1/5) | 6.49 | 0.01108 | 0.041798 |
GO:1903321 | negative regulation of protein modification by small protein conjugation or removal | 20.0% (1/5) | 6.49 | 0.01108 | 0.041798 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 20.0% (1/5) | 6.49 | 0.01108 | 0.041798 |
GO:0008016 | regulation of heart contraction | 20.0% (1/5) | 6.47 | 0.011207 | 0.041987 |
GO:0046677 | response to antibiotic | 20.0% (1/5) | 6.61 | 0.010192 | 0.042235 |
GO:0031960 | response to corticosteroid | 20.0% (1/5) | 6.44 | 0.01146 | 0.042356 |
GO:0071322 | cellular response to carbohydrate stimulus | 20.0% (1/5) | 6.44 | 0.01146 | 0.042356 |
GO:0022407 | regulation of cell-cell adhesion | 20.0% (1/5) | 6.54 | 0.010699 | 0.04241 |
GO:0097060 | synaptic membrane | 20.0% (1/5) | 6.54 | 0.010699 | 0.04241 |
GO:0097193 | intrinsic apoptotic signaling pathway | 20.0% (1/5) | 6.54 | 0.010699 | 0.04241 |
GO:0051384 | response to glucocorticoid | 20.0% (1/5) | 6.59 | 0.010319 | 0.042439 |
GO:0001505 | regulation of neurotransmitter levels | 20.0% (1/5) | 6.51 | 0.010953 | 0.042492 |
GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 20.0% (1/5) | 6.51 | 0.010953 | 0.042492 |
GO:0045637 | regulation of myeloid cell differentiation | 20.0% (1/5) | 6.52 | 0.010826 | 0.042604 |
GO:0032355 | response to estradiol | 20.0% (1/5) | 6.57 | 0.010446 | 0.042641 |
GO:0033673 | negative regulation of kinase activity | 20.0% (1/5) | 6.56 | 0.010573 | 0.042839 |
GO:1903522 | regulation of blood circulation | 20.0% (1/5) | 6.39 | 0.01184 | 0.043468 |
GO:0048167 | regulation of synaptic plasticity | 20.0% (1/5) | 6.38 | 0.011967 | 0.04364 |
GO:0048259 | regulation of receptor-mediated endocytosis | 20.0% (1/5) | 6.35 | 0.01222 | 0.044269 |
GO:0050920 | regulation of chemotaxis | 20.0% (1/5) | 6.33 | 0.012347 | 0.044433 |
GO:0045177 | apical part of cell | 20.0% (1/5) | 6.29 | 0.012727 | 0.045501 |
GO:0034766 | negative regulation of ion transmembrane transport | 20.0% (1/5) | 6.26 | 0.01298 | 0.045514 |
GO:0043279 | response to alkaloid | 20.0% (1/5) | 6.26 | 0.01298 | 0.045514 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 20.0% (1/5) | 6.27 | 0.012854 | 0.045655 |
GO:0090257 | regulation of muscle system process | 20.0% (1/5) | 6.23 | 0.013233 | 0.046106 |
GO:0034763 | negative regulation of transmembrane transport | 20.0% (1/5) | 6.2 | 0.013486 | 0.046397 |
GO:0043271 | negative regulation of ion transport | 20.0% (1/5) | 6.2 | 0.013486 | 0.046397 |
GO:0043409 | negative regulation of MAPK cascade | 20.0% (1/5) | 6.19 | 0.013613 | 0.04654 |
GO:0000911 | cytokinesis by cell plate formation | 20.0% (1/5) | 6.16 | 0.013866 | 0.04711 |
GO:0045471 | response to ethanol | 20.0% (1/5) | 6.15 | 0.013993 | 0.047246 |
GO:0098797 | plasma membrane protein complex | 20.0% (1/5) | 6.14 | 0.014119 | 0.047381 |
GO:1901215 | negative regulation of neuron death | 20.0% (1/5) | 6.13 | 0.014246 | 0.047514 |
GO:0017157 | regulation of exocytosis | 20.0% (1/5) | 6.06 | 0.014878 | 0.049322 |
GO:0043523 | regulation of neuron apoptotic process | 20.0% (1/5) | 6.04 | 0.01513 | 0.049559 |
GO:0045121 | membrane raft | 20.0% (1/5) | 6.04 | 0.01513 | 0.049559 |
GO:0098857 | membrane microdomain | 20.0% (1/5) | 6.03 | 0.015257 | 0.049675 |